Format

Send to

Choose Destination
J Gen Intern Med. 2010 Feb;25(2):154-7. doi: 10.1007/s11606-009-1148-9. Epub 2009 Nov 5.

Prevention of type 2 diabetes: risk status, clinic, and community.

Author information

1
Hubert Department of Global Health, The Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322, USA. knaraya@emory.edu

Abstract

Although the idea of preventing type 2 diabetes has been articulated since the discovery of insulin, only in the past decade have clinical trials demonstrated that diabetes can be prevented or delayed. These trials found lifestyle intervention reduces diabetes incidence by over 50% and is more efficacious than metformin. Evidence from prevention trials comes from persons with "pre-diabetes" in which blood glucose levels are elevated but not yet in the diabetes range. In normoglycemic persons, lifestyle or drug intervention has little impact on diabetes incidence. Prevention programs are often conducted outside the clinical sector where participants' glycemic status is usually unknown; these programs may include many normoglycemic participants, which greatly reduces cost-effectiveness. An economically sustainable system for diabetes prevention will require effective partnerships among the clinical sector, community-based lifestyle programs, and third-party payers to ensure that limited resources for diabetes prevention are focused on persons at high risk of diabetes.

PMID:
19890677
PMCID:
PMC2837490
DOI:
10.1007/s11606-009-1148-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center